



Advancements in CAR-T Cell Therapy: Innovations and Current Challenges in Clinical Applications
UPENN-ISU & Liv Hospital Group Joint Program
16,17 January 2026
ISTANBUL, TURKEY
The Speakers
04
CART THERAPHY EXPERTS
Başak Adaklı Aksoy, MD
MedicalPark Hospital
Pediatric Hematology and Oncology
Fatma Visal Okur, MD
Pediatric Hematology and Oncology specialist
04
Koray Yalçın,MD
MedicalPark Hospital
Pediatric Hematology and Oncology
Özgür Tataroğlu, PhD
Business Director, Liv Hospital Vadistanbul Cellular Therapy Program
Ayca İlter Tataroğlu, PhD
Scientific Director, Liv Hospital Vadistanbul Cellular Therapy Program
Agenda - Day 1
16 January 2026
08:00 - 09:00
09:00 - 09:15
Registration & Welcome Coffee
Opening Speech - Meri Istiroti, Jack Ende, MD & Itır Demiriz, MD
Session 1
Hematology – Leukemia - Jack Ende, MD & Meral Beksaç, MD
09:15-10:00
Acute and Chronic Leukemia | David Porter, MD
10:00-10:45
Lymphomas | Marco Ruella, MD
10:45-11:30
Multiple Myeloma | Alfred Garfall, MD
11:30-11:45
Coffee Break & Networking
11:45-12:30
Multiple Myeloma | - Meral Beksaç, MD - European Myeloma Network
12:30-14:00
Lunch Break
14:00-14:45
CAR-T Cell Therapy and New Approaches | Carl H June, MD(Virtual attendance)
Session 2
Pediatric - Session Chairs - Prof. Tülin Tıraje Celkan, MD & Prof. Tunç Fışgın, MD
14:45-15:15
General approach to Car-T Applications in Pediatrics – Fatma Visal Okur, MD
15:15-15:45
Car-T Cell treatments in ALL patients – Koray Yalçın, MD
15:45-16:15
Coffee Break & Networking
16:15-16:45
Car-T Cell applications in Solid Tumors – Başak Adaklı Aksoy, MD
16:45-17:00
Panel Discussion & Q&A
17:00-17:30
Experts’ Insights & Open Forum for Discussion
Agenda - Day 2
17 January 2026
Session 1 – Complications and Toxicities panel chairs: Mehmet Hilmi Doğu, MD & David Porter, MD
09:00-09:45
New evidence in the pathogenesis of Car-T toxicities and future strategies to overcome them - Marco Ruella, MD
09:45-10:30
Car-T toxicities: Crs, Icans but also delayed neurotoxcity, Secondary Malignancies, Cardiac Complications, Infections and Prophylaxis – Alfred Garfall, MD
10:30-10:45
Coffee Break & Networking
Session 2 – New areas chairs: Marco Ruella, MD & Itır Şirinoğlu Demiriz, MD
10:45-11:15
Car-T for solid tumors from the lab to the clinic: The UPENN experıence - Janos Tanyi, MD, PhD
11:15-11:45
Autoimmune Disease Disorders: The new frontiers for Car-T – David Porter, MD
11:45-12:30
Lunch Break
Session 3 – Liv Hospital CAR-T Program
12:30-13:00
Liv Hospital Vadi CAR-T Manufacturing Facility - Özgür Tataroğlu, PhD
13:00-13:30
CAR-T Cell Therapy Program at Liv Hospital Vadi - Ayca İlter Tataroğlu, PhD
Panel Discussion & Q&A
13:30-14:15
Experts’ Insights & Open Forum for Discussion
Closing Remarks & Certificates Distribution


The Venue
Liv Hospital Vadi Conference Hall
The Liv Hospital Vadi Conference Hall offers a sophisticated and versatile venue perfect for a wide range of corporate and medical events. Located within the esteemed Liv Hospital Vadiistanbul, our modern facility is designed to host productive and engaging gatherings.
With a comfortable capacity for 150 attendees, the main hall provides an ideal setting for conferences, seminars, workshops, and presentations. Beyond the main auditorium, you'll find a spacious foyer area, perfect for registration, coffee breaks, and networking. This welcoming space also provides ample room for companies to set up exhibition stands, offering excellent opportunities for showcasing products, services, or research in a professional environment.
02
17
120
DAY
SPEAKERS
PARTICIPANTS
Our sponsors and Key partners





